![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety, Efficacy, and Pharmacokinetics of Ibalizumab in Treatment-Experienced HIV-1 Infected Patients: a Phase 2b Study
|
|
|
Reported by Jules Levin
51st Interscience Conference on Antimicrobial Agents and Chemotherapy
September 17-20, 2011 | Chicago, IL, USA
H. KHANLOU1, J. GATHE2, S. SCHRADER3, W. TOWNER4, S. WEINHEIMER5, S. LEWIS5. 1
AIDS Health Care Fndn., Los Angeles, CA, 2Therapeutic Concepts, Houston, TX, 3Res. Access Network, Houston, TX, 4Kaiser Permanente, Los Angeles, CA, 5TMB USA, Irvine, CA
![ICAAC1.gif](../images/092211/092211-1/ICAAC1.gif)
![ICAAC2.gif](../images/092211/092211-1/ICAAC2.gif)
![ICAAC3.gif](../images/092211/092211-1/ICAAC3.gif)
![ICAAC4.gif](../images/092211/092211-1/ICAAC4.gif)
![ICAAC5.gif](../images/092211/092211-1/ICAAC5.gif)
![ICAAC6.gif](../images/092211/092211-1/ICAAC6.gif)
![ICAAC7.gif](../images/092211/092211-1/ICAAC7.gif)
![ICAAC8.gif](../images/092211/092211-1/ICAAC8.gif)
![ICAAC9.gif](../images/092211/092211-1/ICAAC9.gif)
![ICAAC10.gif](../images/092211/092211-1/ICAAC10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|